0001609251-20-000008.txt : 20201208 0001609251-20-000008.hdr.sgml : 20201208 20201208172126 ACCESSION NUMBER: 0001609251-20-000008 CONFORMED SUBMISSION TYPE: 13F-HR/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20201208 DATE AS OF CHANGE: 20201208 EFFECTIVENESS DATE: 20201208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Krensavage Asset Management, LLC CENTRAL INDEX KEY: 0001609251 IRS NUMBER: 262520930 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR/A SEC ACT: 1934 Act SEC FILE NUMBER: 028-16807 FILM NUMBER: 201376122 BUSINESS ADDRESS: STREET 1: 610 FIFTH AVENUE STREET 2: SUITE 301 CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 212-888-1582 MAIL ADDRESS: STREET 1: 610 FIFTH AVENUE STREET 2: SUITE 301 CITY: NEW YORK STATE: NY ZIP: 10020 13F-HR/A 1 primary_doc.xml 13F-HR/A LIVE false false false 0001609251 XXXXXXXX 09-30-2020 09-30-2020 true 1 RESTATEMENT Krensavage Asset Management, LLC

610 FIFTH AVENUE SUITE 301 NEW YORK NY 10020

13F HOLDINGS REPORT 028-16807 N Kelly Ireland 212-518-1970 /s/ Kelly Ireland New York NY 12-08-2020 0 11 314096 false INFORMATION TABLE 2 Krensavage13F_09302020AMEND.xml KRENSAVAGE 13F AMEND 09.30.2020 ALKERMES PLC COM G01767105 26055 1572395 SH SOLE 1572395 0 0 ALEXION PHARMACEUTICALS INC COM 015351109 45380 396575 SH SOLE 396575 0 0 ANAPTYSBIO INC COM 032724106 1753 118858 SH SOLE 118858 0 0 BIOGEN INC COM 09062X103 38910 137163 SH SOLE 137163 0 0 ENANTA PHARMACEUTICALS INC COM 29251M106 37784 825329 SH SOLE 825329 0 0 INVACARE CORP COM 461203101 6625 880920 SH SOLE 880920 0 0 MCKESSON CORP COM 58155Q103 27705 186030 SH SOLE 186030 0 0 REGENERON PHARMACEUTICALS COM 75886F107 46046 82258 SH SOLE 82258 0 0 SURGALIGN HOLDINGS INC COM 86882C105 11315 6251208 SH SOLE 6251208 0 0 TARO PHARMACEUTICAL INDUS COM M8737E108 29475 537378 SH SOLE 537378 0 0 UNITED THERAPEUTICS CORP COM 91307C102 43048 426215 SH SOLE 426215 0 0